Source:http://linkedlifedata.com/resource/pubmed/id/17439908
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2007-4-18
|
pubmed:abstractText |
Common disability scales in multiple sclerosis (MS) are often weighted towards physical disability. Non-motor symptoms such as depression, fatigue and pain substantially influence wellbeing in MS. Health-related quality of life (HRQoL) measures the broader impact of MS and might indicate less obvious disease burdens. We analysed HRQoL, using the Nottingham Health Profile Part I (NHP-I), among 345 secondary progressive MS (SPMS) patients participating in a randomized trial of interferon-beta1a (IFN-beta1a), 22 mug subcutaneously weekly, or matching placebo. The results did not reveal any beneficial effect of IFN-beta1a in any outcome measure. NHP-I sub- and sum scores were compared for 217 population controls and correlated with demographic and clinical disease variables. SPMS patients had lower NHP-I sum and all subscores than the controls. Patients experiencing disease progression reported worse NHP-I sum scores. Increased fatigue, Expanded Disability Status Scale (EDSS) and Arm Index scores were independently associated with reduction in several NHP-I subscores. SPMS patients had significantly lower HRQoL than controls and physical disability (EDSS and Arm Index), disease progression and fatigue strongly influenced this. MS.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1352-4585
|
pubmed:author |
pubmed-author:AarsethJ HJH,
pubmed-author:AndersenOO,
pubmed-author:BeiskeA GAG,
pubmed-author:ElovaaraII,
pubmed-author:FarkkilaMM,
pubmed-author:HansenH JHJ,
pubmed-author:MellgrenS ISI,
pubmed-author:MyhrK MKM,
pubmed-author:NaessHH,
pubmed-author:Nordic SPMS study group,
pubmed-author:Sandberg-WollheimMM,
pubmed-author:SorensenP SPS
|
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
386-92
|
pubmed:dateRevised |
2007-8-3
|
pubmed:meshHeading |
pubmed-meshheading:17439908-Disease Progression,
pubmed-meshheading:17439908-Emotions,
pubmed-meshheading:17439908-Fatigue,
pubmed-meshheading:17439908-Female,
pubmed-meshheading:17439908-Health Status,
pubmed-meshheading:17439908-Humans,
pubmed-meshheading:17439908-Male,
pubmed-meshheading:17439908-Mobility Limitation,
pubmed-meshheading:17439908-Multiple Sclerosis, Chronic Progressive,
pubmed-meshheading:17439908-Pain,
pubmed-meshheading:17439908-Quality of Life,
pubmed-meshheading:17439908-Sleep,
pubmed-meshheading:17439908-Social Isolation
|
pubmed:year |
2007
|
pubmed:articleTitle |
Health-related quality of life in secondary progressive multiple sclerosis.
|
pubmed:affiliation |
Department of Neurology, University Hospital of Akershus, Lørenskog, Norway. antonie.beiske@ahus.no
|
pubmed:publicationType |
Journal Article,
Multicenter Study
|